5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Historically, a high burden of resistance to antiretroviral therapy (ART) in heavily treatment-experienced (HTE) persons with HIV (PWH) resulted in limited treatment options (LTOs). We evaluated the prevalence, risk factors, and virologic control of HTE PWH with LTO throughout the modern ART era.

          Related collections

          Author and article information

          Journal
          AIDS
          AIDS (London, England)
          Ovid Technologies (Wolters Kluwer Health)
          1473-5571
          0269-9370
          November 15 2020
          : 34
          : 14
          Affiliations
          [1 ] Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, Washington.
          [2 ] Department of Medicine, Division of Infectious Diseases, University of Alabama Birmingham, Birmingham, Alabama.
          [3 ] Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
          [4 ] Department of Medicine, Division of Infectious Diseases & Global Public Health, University of California, San Diego, California.
          [5 ] Department of Medicine, Division of Infectious Diseases, Baltimore, Johns Hopkins University, Maryland, USA.
          [6 ] Department of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio.
          [7 ] Department of Medicine, Division of Infectious Diseases, Fenway Health, Boston, Massachusetts.
          [8 ] Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, California.
          [9 ] ViiV Healthcare, Research Triangle Park, North Carolina, USA.
          Article
          NIHMS1629895 00002030-202011150-00008
          10.1097/QAD.0000000000002679
          7606534
          33055569
          a5703e2d-4a88-4c71-b949-d4957afded6e
          History

          Comments

          Comment on this article